Notable reductions in the cardiac fibrosis area, collagen deposition, and TGF-β/SMAD2/SMAD3 activation were also observed in DMF-treated DIC model mice (Figure 9L and 9M). The gene discussed is TGFB1; the disease is fibrosis.